Then, miR-1272-ADAM9 signaling can regulate the expression of CDCP1, and CDCP1 acts as an oncogene in glioma, thus suggesting that CDCP1 may participate in glioma progression and the miR-1272-ADAM9 signaling pathway. This evidence concerns the gene ADAM9 and central nervous system cancer.